New York, NYNCT07284472Now EnrollingIRB Ready

Agitation Associated With Alzheimer's Disease Dementia Clinical Trial in New York, NY

Access cutting-edge agitation associated with alzheimer's disease dementia treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Exciva GmbH

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access agitation associated with alzheimer's disease dementia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related agitation associated with alzheimer's disease dementia treatment provided free

Apply for This New York Location

Check if you qualify for this agitation associated with alzheimer's disease dementia clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Agitation Associated With Alzheimer's Disease Dementia Study in New York

The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

Sponsor: Exciva GmbH

Who Can Participate

Inclusion Criteria

The participant is an adult male or female between the ages of 55 to 90 years inclusively, who can move around by themselves, with a walker or a wheelchair.
A previously established diagnosis of AD dementia.
The participant has clinically significant, moderate/severe agitation at the time of screening and for at least 2 weeks prior to randomization
The diagnosis of agitation must meet the International Psychogeriatric Association (IPA) provisional definition of agitation.
Caregiver who is able and willing to comply with all required study procedures and who is in contact with the participant at least on four individual days for at least two hours per day.

Exclusion Criteria

The participant has a confirmed primary diagnosis of a dementia-related disease other than AD dementia.
The participant has symptoms of agitation that are not secondary to AD dementia
The participant has a history of uncontrolled seizures or a history of epilepsy.
The participant has a major medical illness or unstable medical condition

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07284472) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Agitation Associated With Alzheimer's Disease Dementia Treatment Options in New York, NY

If you're searching for agitation associated with alzheimer's disease dementia treatment options in New York, NY, this clinical trial (NCT07284472) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced agitation associated with alzheimer's disease dementia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all agitation associated with alzheimer's disease dementia clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in New York, NY

See all alzheimers disease clinical trials recruiting in New York — not just this study.

Browse Alzheimers Disease Trials in New York →

Browse More Trials by Condition

Alzheimers Disease TrialsAnkylosing Spondylitis TrialsErectile Dysfunction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY